BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
3.830
+0.021 (0.55%)
Jul 16, 2026, 3:54 PM EST
BioStem Technologies Market Cap
BioStem Technologies has a market cap or net worth of $66.46 million as of July 17, 2026. Its market cap has decreased by -66.91% in one year.
Market Cap
66.46M
Enterprise Value
56.03M
Revenue
37.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.83
ChartMarket Cap Chart
Since August 4, 2009, BioStem Technologies's market cap has increased from 4.77M to 66.46M, an increase of 1,291.97%. That is a compound annual growth rate of 16.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 67.52M | 5.48% |
| Dec 31, 2025 | 64.01M | -72.22% |
| Dec 31, 2024 | 230.43M | 143.12% |
| Dec 29, 2023 | 94.78M | 160.66% |
| Dec 30, 2022 | 36.36M | 267.00% |
| Dec 30, 2021 | 9.91M | -25.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 124.23M |
| HST Global | 99.00M |
| NDT Pharmaceuticals | 71.78M |
| Cell Source | 58.43M |
| Nuo Therapeutics | 47.44M |
| Vicapsys Life Sciences | 47.26M |
| Arch Biopartners | 40.76M |
| ProText Mobility | 33.41M |